Email Updates

Search form

You are here

19 JULY 2019 VOLUME 20 ISSUE 27

Media Coverage

  • In the whole of the US drug pricing debate, few drugs have drawn more controversy in recent months than Truvada, the HIV prevention pill from Gilead Sciences. It costs around $20,000 a year, and it was the subject of a fiery Congressional hearing earlier this year. Yet there’s still a huge market opportunity in HIV prevention pills, according to new reports out Friday morning from Citi Research. They argue that the US market for HIV prevention drugs, called PrEP, will more than double to $5.5 billion by 2030.

    July 19, 2019
    Barron's
  • A vaginal ring inserted monthly could reduce women’s risk of contracting HIV by 63 percent, according to a recent study. The ring is loaded with the antiretroviral drug (ARV) dapivirine, which is slowly released into wearers’ blood to help prevent HIV infection. The flexible, silicon band — developed by the nonprofit organisation International Partnership for Microbicides (IPM) — is the first long-acting form of treatment that HIV-negative women can take before being exposed to HIV to reduce their chances of contracting the virus.

    July 19, 2019
    Mail & Guardian
  • Chinese scientists will begin the second-phase clinical trial of an HIV vaccine on 160 volunteers, Friday's China Daily reported. The candidate vaccine, DNA-rTV, relies on replication of the DNA of HIV to stimulate effective immunization, according to Shao Yiming, a chief HIV researcher at the Chinese Center for Disease Control and Prevention, adding that it's the first such HIV vaccine to begin a second-phase clinical trial.

    July 19, 2019
    Xinhua
  • A new report says Kenya is among 18 countries globally whose HIV/AIDS prevalence rate stands at below three per cent. The report by the United Nations Programme on HIV/AIDS (UNAIDS) asserts that at below three per cent, the country is doing fine. This is the benchmark HIV/AIDS prevalence rate that the agency has set to ensure that countries are moving towards eliminating the pandemic.

    July 18, 2019
    Standard Digital
  • Recruitment of participants for the experimental vaccine for Ebola Sudan has started in Kampala. At least 40 people comprising males and females are expected to participate in the 48 week’s study by Makerere Walter Reed Project.

    July 18, 2019
    General
    Independent
  • The HIV treatments of tomorrow promise to last even longer, and they'll be available sooner than you think.

    July 18, 2019
    HIV Plus Mag
  • In the battle to stop the spread of HIV, the medical community relies on a critical weapon called pre-exposure prophylaxis. Known as PrEP, the powerful drug regimen can keep healthy but at-risk people from getting infected. But a study released Thursday reveals the existence of "PrEP deserts": regions of the country home to people at high risk of contracting HIV, but with no PrEP-providing clinic nearby.

    July 18, 2019
    US News & World Report
  • Efforts to manage the HIV epidemic in much of sub-Saharan Africa need to specifically target sections of the population that are most vulnerable to HIV infection. Two such key populations include men who have sex with men and transgender women. But in many countries on the continent same sex relationships – and transgender identities – are criminalised.

    July 18, 2019
    General
    The Conversation
  • Universal test-and-treat strategies resulted in "modest to no reductions" in new HIV transmissions in three large population-based studies, writes Salim Abdool-Karim, MD, ChB, PhD, of the Centre for the AIDS Programme of Research in South Africa, in a commentary published online today in the New England Journal of Medicine. But that doesn't necessarily mean that expanding diagnoses and offering immediate access to HIV medicines is ineffective at stopping HIV transmission, said Myron Cohen, MD, of the University of North Carolina School of Medicine in Chapel Hill.

    July 17, 2019
    Medscape
  • For Wendy Armstrong, MD, who still sees patients die from complications of AIDS, news of monthly injectable HIV treatment, simplified regimens, and better tolerated antiretroviral drugs are exciting. But they're also frustrating.

    July 17, 2019
    Medscape
  • Imagine that 90 percent of all people living with HIV were diagnosed and treated with drugs. Would that be sufficient to end the AIDS epidemic? Scientists tried to answer the question in three enormous studies published on Wednesday in the New England Journal of Medicine. Instead of simply urging people to get testing and treatment for HIV, health workers in five African countries went door to door, or set up mobile sites, offering tests for HIV, tuberculosis and other diseases to everyone in certain communities.

    July 17, 2019
    New York Times
  • The latest UNAIDS Global AIDSUpdate report, released on Tuesday in the small KwaZulu-Natal town of Eshowe - believed to be the epicentre of the epidemic in SA - found that reaching young men for HIV testing and treatment services "is a major challenge".

    July 17, 2019
    Times LIVE
  • When it was announced earlier this year, Trump’s plan to end the HIV epidemic within a decade was met with mixed reviews. Heralded for good intentions, many advocates and policy makers still questioned its strategy (and the commitment of an administration that remains determined to dismantle the Affordable Care Act, which has had demonstrable positive impacts on slowing the epidemic and improving the lives of those living with HIV).

    July 17, 2019
    General
    HIV Plus Mag
  • UNAIDS, a joint United Nations Program advocating for accelerated and global action on HIV/AIDS, has reported that deaths from the pandemic are falling. Data recently published by the organization shows that there were 770,000 AIDS-related deaths worldwide last year, a 33 percent decline on 2010. Even though that may seem like good news, the pace of progress in reducing new infections, increasing access to treatment and ending deaths is actually slowing down.

    July 17, 2019
    General
    Forbes
  • For more than 50 years, the RNA remained hidden in a lymph node that had been snipped out of a 38-year-old man in what is now the Democratic Republic of the Congo. That nub of tissue, the size of a nail on a pinky finger, had been sealed up in a protective block of paraffin.

    July 16, 2019
    General
    STAT
  • Two years ago, Nigeria was a battleground. Not just a literal one — though authorities were facing the mounting death tolls of Boko Haram attacks — but an immunological one. The country had just over 3 million people with HIV, second in the world only to South Africa. Roughly 8 percent of all the HIV-positive people in the world lived in Nigeria, which has less than 3 percent of the world’s overall population.

    July 16, 2019
    General
    OZY
  • A woman who walks into a standard family planning clinic in Kenya is often not told an obvious truth – only condoms can protect you from Sexually Transmitted Infections (STIs). For that simple advice, she must go to a separate outpatient clinic, or an STI or HIV clinic.

    July 13, 2019
    Daily Nation

Published Research

Announcements